Health Care & Life Sciences » Pharmaceuticals | J.B. Chemicals & Pharmaceuticals Ltd.

J.B. Chemicals & Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
10,011
11,210
11,712
13,133
13,877
16,432
Cost of Goods Sold (COGS) incl. D&A
6,571
7,591
8,139
9,251
9,479
9,403
Gross Income
3,440
3,620
3,573
3,882
4,398
7,029
SG&A Expense
2,335
2,132
2,049
2,254
2,959
4,532
EBIT
1,051
1,434
-
-
1,424
2,498
Unusual Expense
467
2
28
33
167
-
Non Operating Income/Expense
340
75
427
744
701
414
Interest Expense
62
68
106
35
35
42
Pretax Income
874
1,455
2,122
2,299
1,940
2,870
Income Tax
259
451
496
455
552
930
Consolidated Net Income
615
1,004
1,627
1,844
1,387
1,940
Net Income
615
1,004
1,625
1,841
1,383
1,935
Net Income After Extraordinaries
615
1,004
1,625
1,841
1,383
1,935
Net Income Available to Common
615
1,004
1,625
1,841
1,383
1,935
EPS (Basic)
7.26
11.84
19.16
21.70
16.48
23.54
Basic Shares Outstanding
85
85
85
85
84
-
EPS (Diluted)
7.26
11.84
19.16
21.70
16.48
-
Diluted Shares Outstanding
85
85
85
85
84
-
EBITDA
1,331
1,820
2,160
2,083
1,993
3,054
Other Operating Expense
54
54
224
17
15
-
Non-Operating Interest Income
13
13
12
12
17
-
Minority Interest Expense
-
-
1
3
4
5
Equity in Affiliates (Pretax)
-
-
14
-
-
-

About J.B. Chemicals & Pharmaceuticals

View Profile
Address
Neelam Centre, B Wing
Mumbai Maharashtra 400030
India
Employees -
Website http://www.jbcpl.com
Updated 07/08/2019
JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. It operates through the following business units: India; Russia & CIS; Global; Contrast Media; API; and Business Development. The India business unit produces medicine for gastro, cardiac, and pain management.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.